Published in
Dove Press, OncoTargets and Therapy, (Volume 12), p. 4543-4554, 2019
DOI: 10.2147/ott.s177844
Links
Tools
<p>Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date</p>
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 